C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer - Logullo, Angela F.; Lopes, Andreia B. G.; Nonogaki, Suely; Soares, Fernando A.; Mourão Netto, Mario; Nishimoto, Inês N.; Brentani, M. Mitzi (Oncology reports, 2007)